F M Investments LLC bought a new position in Veralto Co. (NYSE:VLTO – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 12,514 shares of the company’s stock, valued at approximately $1,380,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. James Investment Research Inc. bought a new stake in shares of Veralto during the 3rd quarter valued at $211,000. Farther Finance Advisors LLC lifted its position in shares of Veralto by 6.9% in the third quarter. Farther Finance Advisors LLC now owns 2,353 shares of the company’s stock valued at $263,000 after acquiring an additional 152 shares in the last quarter. Capital Advisors Inc. OK boosted its stake in shares of Veralto by 33.9% in the third quarter. Capital Advisors Inc. OK now owns 321,679 shares of the company’s stock worth $35,983,000 after acquiring an additional 81,363 shares during the period. Cigna Investments Inc. New grew its position in shares of Veralto by 8.9% during the third quarter. Cigna Investments Inc. New now owns 2,576 shares of the company’s stock worth $288,000 after purchasing an additional 210 shares in the last quarter. Finally, Pinnacle Associates Ltd. raised its stake in Veralto by 16.6% during the 3rd quarter. Pinnacle Associates Ltd. now owns 7,549 shares of the company’s stock valued at $844,000 after purchasing an additional 1,072 shares during the period. Institutional investors own 91.28% of the company’s stock.
Insider Buying and Selling at Veralto
In other news, CEO Jennifer Honeycutt sold 13,191 shares of Veralto stock in a transaction on Friday, August 30th. The stock was sold at an average price of $111.98, for a total transaction of $1,477,128.18. Following the completion of the sale, the chief executive officer now directly owns 138,546 shares in the company, valued at approximately $15,514,381.08. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, SVP Surekha Trivedi sold 7,399 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $110.00, for a total value of $813,890.00. Following the completion of the sale, the senior vice president now owns 12,671 shares in the company, valued at approximately $1,393,810. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jennifer Honeycutt sold 13,191 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $111.98, for a total value of $1,477,128.18. Following the transaction, the chief executive officer now owns 138,546 shares in the company, valued at $15,514,381.08. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 35,286 shares of company stock valued at $3,912,305 in the last quarter. 0.31% of the stock is owned by insiders.
Veralto Stock Down 0.6 %
Veralto (NYSE:VLTO – Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.85 by $0.04. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.30 billion. Veralto had a net margin of 15.69% and a return on equity of 52.85%. The firm’s revenue was up 4.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.75 EPS. On average, analysts predict that Veralto Co. will post 3.48 earnings per share for the current year.
Veralto Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Friday, September 27th were paid a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date was Friday, September 27th. Veralto’s dividend payout ratio is currently 11.11%.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group increased their price objective on shares of Veralto from $104.00 to $116.00 and gave the company a “buy” rating in a report on Monday, July 29th. Stifel Nicolaus lifted their price target on shares of Veralto from $117.00 to $119.00 and gave the company a “buy” rating in a report on Wednesday, October 16th. BMO Capital Markets increased their price objective on shares of Veralto from $117.00 to $119.00 and gave the company an “outperform” rating in a report on Monday, September 30th. UBS Group began coverage on Veralto in a report on Tuesday, August 13th. They issued a “neutral” rating and a $118.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Veralto from $100.00 to $109.00 and gave the company a “hold” rating in a report on Monday, July 29th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Veralto currently has a consensus rating of “Hold” and an average target price of $108.27.
Get Our Latest Report on Veralto
Veralto Company Profile
Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.
See Also
- Five stocks we like better than Veralto
- Bank Stocks – Best Bank Stocks to Invest In
- Battle of the Retailers: Who Comes Out on Top?
- Are Penny Stocks a Good Fit for Your Portfolio?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Veralto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veralto and related companies with MarketBeat.com's FREE daily email newsletter.